Mindray
Chinese medical equipment manufacturer. Strongest in patient monitoring + ultrasound + in-vitro diagnostics. Ultrasound product lines compete in the mid-market globally — Resona + DC + M-series carts, plus handheld ultrasound.
Company history
- 1991 — founded in Shenzhen by Xu Hang + co-founders (former partners at an industrial-electronics firm).
- Late 1990s–2000s — grows in Chinese domestic patient-monitoring market, expands to IVD.
- 2008 — IPO on NYSE.
- 2008 — acquires Datascope Patient Monitoring (US) — establishes US/Europe footprint.
- 2015–2017 — goes private; relists on Shenzhen Stock Exchange 2018.
- 2020s — significant push into high-end ultrasound (Resona 9 / R9 premium) + continues global patient-monitoring expansion.
Product line
- Ultrasound — Resona family (premium: R9, R7, R5), DC-series (mid-market), M-series (portable)
- Patient monitoring — BeneVision central-station + bedside monitors, BeneHeart defibrillators
- In vitro diagnostics — hematology (BC-series), chemistry (BS-series), immunology
- Anesthesia machines — A-series
Market position
Leader in patient monitoring globally (especially post-COVID expansion). Mid-market + rising premium ultrasound player. Not competitive with Philips iU22 / Epiq or GE Logiq E9/E10 at the very top, but Resona 9 narrows the gap meaningfully + at lower capital cost.